Implied Podcast

BYD’s US-listed shares have plunged nearly 45% from their 52-week peak down to $8.29, even as the EV giant posts 28% net profit growth and exports more cars in a single quarter than Tesla sells globally. Why is Wall Street punishing the stock? Because ballooning inventory and a 45% drop in cash reserves prove that aggressive global expansion—including a potential third European plant in Spain—come...

Affirm just suffered a brutal 18% drop from its recent $80 peak, despite posting a monster quarter with a record $14.4 billion in merchandise volume and a 112% explosion in active cardholders. Why? A surprisingly hot inflation report has Wall Street spooked that rising yields will squeeze margins for the "buy now, pay later" giant, compounded by a tough earnings miss. In this episode of Implied, w...

GE Vernova just suffered a brutal 24% drawdown over the last three months, capped by a sudden 10% single-day cliff dive after SoftBank shook Wall Street by altering its AI data center procurement plans. Investors panicked that the red-hot AI energy trade is losing steam, dragging power equipment giants down across the board. Yet behind the headlines sits a massive $197 billion backlog, expanding m...

Hims & Hers Health just suffered a brutal 18% selloff after third-quarter margins collapsed from 74% to 57% and sequential subscriber numbers dropped. Despite revenue jumping 49%, Wall Street hit the panic button over slashed EBITDA guidance, soft forecasts, and insider stock sales. In this episode of Implied, we break down what’s really driving the margin squeeze, how international expansion...

ImmunityBio just took a 17% nosedive today, but the headline numbers are masking pure Wall Street irony. Despite posting a massive 53% surge in quarterly revenue and scoring a major FDA label expansion for its flagship cancer drug, Anktiva, investors hit the panic button over a ballooning $184.6 million net loss. In this episode of Implied, we break down why over $100 million of that loss is simpl...

Axon Enterprise just took a massive beating, crashing over 18% to a 52-week low despite posting a record $909 million in Q3 revenue. The catalyst? Wall Street panicked after management lowered their full-year guidance due to $130 million in delayed federal drone deployments. But are investors missing the bigger picture? In this episode of Implied, we break down why this drop might be a severe mark...

Hims & Hers Health (HIMS) just took an absolute beating, shedding nearly 12% in a single session and wiping $600 million off its market cap. The culprit? Panic-selling triggered by a looming class action lawsuit and an FTC probe into billing and privacy practices. But with Q3 earnings days away, projected revenue near $893 million, and a massive new rollout in men's health, is Wall Street over...

Fidelity National Information Services (FIS) just fell off a cliff, crashing nearly 24% in a single session despite beating third-quarter revenue and earnings estimates. What triggered the market panic? A slashed full-year outlook paired with the sudden departure of its CFO shattered management credibility and prompted an immediate Wall Street downgrade. Yet underneath the chaos, FIS trades at an...

Gartner’s stock just suffered a brutal 14% nosedive down to $202, completely wiping out its recent run-up. The catch? The research giant actually crushed Q3 earnings with a 30% jump in profit and raised full-year guidance across the board. So why the massive selloff? Slowing core top-line growth, missed contract exit rate targets, and a stock that was simply priced for perfection. In this episode...

Lumentum just suffered a brutal 18% selloff after Marvell Technology announced a massive $115 billion all-stock takeover—the biggest tech merger of the year. Instead of celebrating, Wall Street panicked over heavy dilution, execution risks, and a distant 2028 closing date, sending both stocks into a tailspin. But with Lumentum posting 109% revenue growth on explosive AI optical demand and shares t...

Coinbase just went into freefall, plunging 25% in a single morning after a brutal Q3 earnings report, a massive $2.2 billion insider stock sale plan, and a sector-wide crypto shock triggered by a $6.3B exploit at rival Binance. While transaction revenue dropped 44% and retail volumes dried up, the company is quietly building momentum in prediction markets, AI-agent trading, and its USDC stablecoin...

Alphabet just shocked the after-hours market with an 8% crash following a Q3 revenue miss. Wall Street had priced in absolute perfection, and when the tech giant fell slightly short on top-line expectations, momentum traders immediately hit the panic button. But with a fortress balance sheet, incredibly strong Cloud margins, and buzzing rumors about OpenAI buying Google TPUs, is this sell-off just...

UniFirst just suffered a total bloodbath, plunging 10% after the FTC signaled its intent to block a massive $5.5 billion buyout from industry giant Cintas. The market instantly wiped out the stock’s acquisition premium, throwing cold water on what seemed like a slam-dunk payday for shareholders. But underneath the regulatory panic lies a fundamentally rock-solid standalone business with more cash...

Brazilian fintech giant XP Inc. just suffered an absolute meltdown, plunging nearly 50% to fresh 52-week lows after a stunning election upset triggered a massive selloff across South American markets. Despite posting over $966M in revenue and double-digit profit growth, XP got caught right in the epicenter of the macro blast as investors hit the panic button over fiscal uncertainty. In this episod...

Bloom Energy just posted a massive Q3 print, crushing expectations with a record $1.24 billion in revenue as it rides the surging AI data center wave. So why did the stock suddenly plunge over 11%? Wall Street completely ignored the shiny top-line numbers and severely punished the company after its operating cash flow plummeted into the red. With Treasury yields hovering near 24-year highs, invest...

Forgent Power Solutions just lost a quarter of its value in a single day, crashing 25% after its CFO suddenly stepped down. But is Wall Street missing the bigger picture? Despite the executive shakeup, Forgent just posted a massive 94% revenue jump, beat EPS estimates, and is sitting on a record-breaking $3 billion backlog. In this episode of Implied, we break down whether this brutal selloff is j...

Telix Pharmaceuticals just took a massive hit, dropping nearly 10% after announcing a $2.35 billion merger with ITM. While buying a top global supplier of therapeutic radioisotopes creates a vertically integrated powerhouse, the market completely freaked out over how Telix is paying for it: severe share dilution. With $1.25 billion of the upfront cost covered by issuing new shares, investors hated...

Sea Limited just took a nasty 7% dive, falling into the low eighties despite posting a massive 48% jump in revenue. Why the selloff? Wall Street is losing patience over Shopee's profit margins, fueled by a major DBS Bank downgrade and recent insider selling. In this episode of Implied, we break down Sea’s high-stakes global war against Amazon in Brazil and TikTok Shop in Asia. Is this pullback a w...

RB Global stock is getting hammered—dropping 8% down to the $77 range as Wall Street panics over short-term auction demand and analyst downgrades. But underneath the noise, Gross Transaction Value jumped 13% to over $4.3B, forward P/E sits at a steep discount, and corporate insiders are quietly loading up on shares. In this episode of Implied, we break down why the market is aggressively repricing...

Qfin Holdings has absolutely cratered, dropping over 70% from its highs after a brutal cocktail of Chinese regulatory crackdowns, an industry-wide liquidity crunch, and a massive 19% single-day crash. With revenues sinking 32% and class-action lawsuits piling up, the market is pricing in a total disaster. But is the fear overblown? In this episode of Implied, we break down why Qfin is now trading...

Dell’s stock is in a massive tailspin, tumbling over 9% today on top of yesterday’s 11% plunge after a sharp Barclays downgrade to Equal Weight chilled the AI hardware trade. With insider sales hitting a staggering $3.5 billion over the last 12 months and a trailing P/E soaring past 29x, was this selloff an inevitable reality check—or an overreaction for a global infrastructure powerhouse? In this...

DigitalOcean just fell off a cliff, plunging 14% and wiping out a tenth of its market value in a single trading session. The crazy part? The company’s fundamentals look solid, boasting strong full-year 2026 earnings guidance and a recent $725 million move to expand its AI cloud capacity. So why the sudden panic? In this episode of Implied, we break down how broader macro tech fears, squeezed cloud...

Summit Therapeutics just got hit with an 8.6% drop, slipping to $15.65 despite massive underlying momentum. Why are investors slamming the sell button on one of biotech’s hottest names right after AstraZeneca backed them with a $2 billion investment? In this episode of Implied, we break down what’s really behind the pull-back—from pre-earnings profit-taking to technical moving average breakdowns....

Ciena just suffered a violent 10% reversal, crashing back to earth after last week's massive AI-networking rally. Despite having the game-changing tech needed to build the future of hyperscale data centers, a nosebleed valuation and physical supply chain bottlenecks are bringing investors back to reality. Throw in some sudden insider selling, and Wall Street is taking profits. In this episode of I...

AST SpaceMobile just took a massive hit, dropping 11.6% after Elon Musk’s SpaceX reportedly snatched up the highly coveted 800 MHz spectrum block it desperately needed. With a painful $230 million net loss, recent share dilution, and heavy insider selling, Wall Street is hitting the panic button on the direct-to-cell startup. But with a $2.7 billion war chest, 13 satellites already in orbit, and a...